IL76289A0 - Tumor therapeutic agent and a process for its preparation - Google Patents
Tumor therapeutic agent and a process for its preparationInfo
- Publication number
- IL76289A0 IL76289A0 IL76289A IL7628985A IL76289A0 IL 76289 A0 IL76289 A0 IL 76289A0 IL 76289 A IL76289 A IL 76289A IL 7628985 A IL7628985 A IL 7628985A IL 76289 A0 IL76289 A0 IL 76289A0
- Authority
- IL
- Israel
- Prior art keywords
- therapeutic agent
- preparation
- tumor therapeutic
- monoclonal antibodies
- antigens
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229940124597 therapeutic agent Drugs 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 102000005348 Neuraminidase Human genes 0.000 abstract 1
- 108010006232 Neuraminidase Proteins 0.000 abstract 1
- 210000005260 human cell Anatomy 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Window Of Vehicle (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Saccharide Compounds (AREA)
Abstract
The process entails either tumour cells which carry antigens which are bound by the monoclonal antibodies described in German Offenlegungsschrift 33 29 184 being dried or stabilised by a chemical treatment, or antigens being isolated from human cells using these monoclonal antibodies, and converted into a therapeutic agent, adding neuraminidase where appropriate.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19843432714 DE3432714A1 (en) | 1984-09-06 | 1984-09-06 | TUMOR THERAPEUTICS AND METHOD FOR THE PRODUCTION THEREOF |
Publications (2)
Publication Number | Publication Date |
---|---|
IL76289A0 true IL76289A0 (en) | 1986-01-31 |
IL76289A IL76289A (en) | 1992-01-15 |
Family
ID=6244749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL76289A IL76289A (en) | 1984-09-06 | 1985-09-04 | Tumor therapeutic agent and a process for its preparation |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0173951B1 (en) |
JP (1) | JPS6168427A (en) |
AT (1) | ATE64531T1 (en) |
CA (1) | CA1277600C (en) |
DE (2) | DE3432714A1 (en) |
DK (1) | DK172253B1 (en) |
ES (1) | ES8704082A1 (en) |
FI (1) | FI88360C (en) |
GR (1) | GR852149B (en) |
IE (1) | IE58638B1 (en) |
IL (1) | IL76289A (en) |
PT (1) | PT81093B (en) |
ZA (1) | ZA856807B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3806565A1 (en) * | 1988-03-01 | 1989-09-14 | Deutsches Krebsforsch | VIRUS-MODIFIED TUMOR VACCINES FOR THE IMMUNOTHERAPY OF TUMOR METAL KEYS |
AT398900B (en) * | 1991-02-12 | 1995-02-27 | Pekar Rudolf Dr | Vaccine for immunotherapy |
US7105159B1 (en) | 1992-11-05 | 2006-09-12 | Sloan-Kettering Institute For Cancer Research | Antibodies to prostate-specific membrane antigen |
DK0668777T3 (en) * | 1992-11-05 | 2007-02-19 | Sloan Kettering Inst Cancer | Prostate-specific membrane antigen |
US7070782B1 (en) | 1992-11-05 | 2006-07-04 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen |
US6953668B1 (en) | 1992-11-05 | 2005-10-11 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen |
US6569432B1 (en) | 1995-02-24 | 2003-05-27 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen and uses thereof |
ATE317435T1 (en) | 1995-02-24 | 2006-02-15 | Sloan Kettering Inst Cancer | PROSTATE SPECIFIC MEMBRANE ANTIGEN AND ITS APPLICATIONS |
DE19506483A1 (en) * | 1995-02-24 | 1996-08-29 | Jens Dr Dr Atzpodien | Antitumour vaccines |
EP3184539A3 (en) | 2001-10-23 | 2017-09-13 | PSMA Development Company L.L.C. | Psma antibodies |
US20050215472A1 (en) | 2001-10-23 | 2005-09-29 | Psma Development Company, Llc | PSMA formulations and uses thereof |
CN1315536C (en) * | 2002-09-13 | 2007-05-16 | 李进 | Novel vaccine of tumor antigen, its preparation method and vaccine composition |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4152410A (en) * | 1975-09-03 | 1979-05-01 | Eisai Co., Ltd. | Diagnosis reagent for neoplasm and method for diagnosis of neoplasm |
DE2643215A1 (en) * | 1976-09-25 | 1978-04-06 | Bayer Ag | CANCEROSTATICALLY EFFECTIVE PREPARATIONS FROM TUMOR CELLS AND A METHOD FOR THEIR PRODUCTION |
ZA776822B (en) * | 1976-11-24 | 1979-06-27 | D Mccollester | Vaccine and method for immunotherapy of neoplastic disease |
DE2918927A1 (en) * | 1979-05-10 | 1980-11-20 | Hans Prof Dr Limburg | MEDICINAL PRODUCT FOR TREATING CARCINOMAS AND METHOD FOR THE PRODUCTION THEREOF |
US4446122A (en) * | 1979-12-28 | 1984-05-01 | Research Corporation | Purified human prostate antigen |
US4468457A (en) * | 1981-06-01 | 1984-08-28 | David M. Goldenberg | Method for producing a CSAp tryptic peptide and anti-CSAp antibodies |
DE3329184A1 (en) * | 1983-08-12 | 1985-02-21 | Behringwerke Ag, 3550 Marburg | MONOCLONAL ANTIBODIES WITH SPECIFICITY FOR MEMBRANE-ASSOCIATED ANTIGENS |
DE3416774A1 (en) * | 1984-05-07 | 1985-11-14 | Behringwerke Ag, 3550 Marburg | MONOCLONAL ANTIBODIES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
-
1984
- 1984-09-06 DE DE19843432714 patent/DE3432714A1/en not_active Withdrawn
-
1985
- 1985-08-27 EP EP85110757A patent/EP0173951B1/en not_active Expired - Lifetime
- 1985-08-27 DE DE8585110757T patent/DE3583265D1/en not_active Expired - Fee Related
- 1985-08-27 AT AT85110757T patent/ATE64531T1/en not_active IP Right Cessation
- 1985-09-03 DK DK402485A patent/DK172253B1/en not_active IP Right Cessation
- 1985-09-04 IL IL76289A patent/IL76289A/en not_active IP Right Cessation
- 1985-09-04 FI FI853389A patent/FI88360C/en not_active IP Right Cessation
- 1985-09-04 ES ES546701A patent/ES8704082A1/en not_active Expired
- 1985-09-04 GR GR852149A patent/GR852149B/el unknown
- 1985-09-05 IE IE219185A patent/IE58638B1/en not_active IP Right Cessation
- 1985-09-05 ZA ZA856807A patent/ZA856807B/en unknown
- 1985-09-05 CA CA000490026A patent/CA1277600C/en not_active Expired - Lifetime
- 1985-09-05 JP JP60195000A patent/JPS6168427A/en active Pending
- 1985-09-05 PT PT81093A patent/PT81093B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI853389L (en) | 1986-03-07 |
CA1277600C (en) | 1990-12-11 |
FI853389A0 (en) | 1985-09-04 |
EP0173951A3 (en) | 1988-06-08 |
DK172253B1 (en) | 1998-02-09 |
EP0173951B1 (en) | 1991-06-19 |
DK402485D0 (en) | 1985-09-03 |
PT81093A (en) | 1985-10-01 |
FI88360B (en) | 1993-01-29 |
DE3432714A1 (en) | 1986-04-24 |
ES546701A0 (en) | 1987-03-16 |
GR852149B (en) | 1986-01-03 |
DK402485A (en) | 1986-03-07 |
DE3583265D1 (en) | 1991-07-25 |
FI88360C (en) | 1993-05-10 |
JPS6168427A (en) | 1986-04-08 |
IE58638B1 (en) | 1993-10-20 |
PT81093B (en) | 1988-07-01 |
ES8704082A1 (en) | 1987-03-16 |
IL76289A (en) | 1992-01-15 |
EP0173951A2 (en) | 1986-03-12 |
IE852191L (en) | 1986-03-06 |
ZA856807B (en) | 1986-04-30 |
ATE64531T1 (en) | 1991-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL90990A0 (en) | Pharmaceutical and diagnostic compositions containing monoclonal antibodies reactive with cachectin and a cell for the production thereof | |
DE3269625D1 (en) | Benzazepin-2-ones, process for their preparation, pharmaceutical preparations containing these compounds and the compounds for therapeutical use | |
EP0161606A3 (en) | Drug, and methods of preparing and using it for treatment of tumors | |
EP0260610A3 (en) | Monoclonal antibodies against human tumour necrotic factor (tnf), and their use | |
HUT71193A (en) | Tumor specific monoclonal antibody and cell line and pharmaceutical preparations containing them | |
NZ210867A (en) | Tumour-specific monoclonal antibodies, production thereof and use | |
ZA856807B (en) | A tumor therapeutic agent and a process for its preparation | |
DE3173342D1 (en) | Agent for tumor localization and therapy with labeled antibodies and antibody fragments | |
ZA897858B (en) | Family of high affinity,modified antibodies for cancer treatment | |
DE3163162D1 (en) | Platinum-isocitrate complex, process for its preparation and its therapeutical application | |
CA2192079A1 (en) | Human Monoclonal Antibodies Specific to Cell Cycle Independent Glioma Surface Antigen | |
EP0194851A3 (en) | Human tumor therapy | |
EP0173663A3 (en) | The use of a specific tumor associated antigen, sialosyllactotetraose, in diagnostic or therapeutic procedures related to cancer deseases | |
EP0268640A4 (en) | Vaccine for stimulating or enhancing production of antibodies directed against gm2. | |
EP0042428A4 (en) | Purified human prostate antigen. | |
HUT36783A (en) | Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane | |
GR862238B (en) | Monoclonal antibodies against glycoprotein associated with tumor, processes for their preparation and their use | |
EP0328578A4 (en) | Antigen recognized by mca 16-88. | |
ES8404693A1 (en) | 14-Amino-steroid derivatives, their therapeutical use and process for their preparation. | |
GB2048069B (en) | Medicinal preparations for treating carcinomas | |
EP0207170A4 (en) | Process for preparing human cancer-specific monoclonal antibody. | |
EP0341318A4 (en) | Novel platinum (ii) complex, process for preparing the same, and therapeutic agent for malignant tumor | |
IE873394L (en) | Material for treatment of ammonia. | |
ZA886752B (en) | Tumor immunotherapy using anti-idiotypic antibodies | |
JPS6490158A (en) | 1,2-diamino compound, manufacture and medicine for treating cardiac disease and circulatory disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
RH1 | Patent not in force |